Andy King
Head of Trials Programming
Andy is responsible for the IT management of the National Perinatal Epidemiology Unit (NPEU) Clinical Trial Unit's (CTU) work, including the computing aspects of the design and conduct of NPEU CTU randomised controlled trials, and has particular responsibility for the randomisation systems.
Since joining the NPEU in 1996, he has worked on numerous projects (including 4Child and UKCP) and clinical trials (including the Hip Trial, INIS, BOOST-II UK, I2S2, PiPS, Poppi and Baby-OSCAR).
After graduating from the University of Oxford with a BA in Mathematics, Andy was self-employed as a computer programmer working for several Oxford colleges and the NHS. In 2009, he became Senior Trials Programmer, and in 2014 was appointed Head of Trials Programming.
Recent publications
-
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2025), EClinicalMedicine, 81
-
Techniques to increase lumbar puncture success in newborn babies: the NeoCLEAR RCT.
Journal article
Roehr CC. et al, (2023), Health Technol Assess, 27, 1 - 97
-
2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Journal article
Clarke P. et al, (2023), Arch Dis Child Fetal Neonatal Ed
-
Frenotomy with breastfeeding support versus breastfeeding support alone for infants with tongue-tie and breastfeeding difficulties: the FROSTTIE RCT.
Journal article
Knight M. et al, (2023), Health Technol Assess, 27, 1 - 73
-
Mixed-methods feasibility study to inform a randomised controlled trial of proton pump inhibitors to reduce strictures following neonatal surgery for oesophageal atresia.
Journal article
Mitchell TK. et al, (2023), BMJ Open, 13